Literature DB >> 32621580

Upper airway collapsibility in patients with OSA treated with continuous positive airway pressure: a retrospective preliminary study.

Marcello Bosi1, Serena Incerti Parenti2, Andrea Fiordelli2, Venerino Poletti3,4, Giulio Alessandri-Bonetti2.   

Abstract

STUDY
OBJECTIVES: To investigate the prevalence of mildly collapsible upper airways (defined by therapeutic continuous positive airway pressure [CPAP] values ≤ 8 cm H₂O) in moderate to severe obstructive sleep apnea patients treated with CPAP and to determine their clinical, functional, and nocturnal polysomnographic characteristics.
METHODS: Eighty-seven patients with moderate to severe obstructive sleep apnea consecutively treated with CPAP were retrospectively investigated. Two nocturnal home sleep portable monitoring studies were performed at baseline and during treatment. Participants were categorized according to therapeutic CPAP values: ≤ 8 cm H₂O (group 1), 8-12 cm H₂O (group 2), ≥ 12 cm H₂O (group 3). Anthropometric, awake respiratory function, symptoms, comorbidities, and nocturnal home sleep portable monitoring studies data were collected.
RESULTS: Mild upper airway collapsibility (therapeutic CPAP values ≤ 8 cm H₂O) was present in 25.3% of patients. They showed more favorable apnea-hypopnea index, oxygen desaturation index, mean nocturnal saturation, sleep time with oxygen saturation < 90%, desaturation nadir, and supine position. Oxygen desaturation index showed a weak association with anatomical collapsibility. Using the receiver operating characteristic curve, the area under the curve for the oxygen desaturation index vs CPAP pressure requirements ≤ 8 cm H₂O was low and oxygen desaturation index ≤ 40.8/h showed a sensitivity of 63.3% and a specificity of 69.2% to detect patients with mild collapsibility.
CONCLUSIONS: A quarter of moderate to severe patients under CPAP therapy had mild collapsibility and were likely to also be good candidates for alternative and better tolerated non-CPAP therapies. Baseline anthropometric, clinical, and respiratory function characteristics did not predict mild upper airway collapsibility determined by CPAP pressure requirements ≤ 8 cm H₂O.
© 2020 American Academy of Sleep Medicine.

Entities:  

Keywords:  continuous positive airway pressure; obstructive sleep apnea; upper airway collapsibility

Year:  2020        PMID: 32621580      PMCID: PMC8034204          DOI: 10.5664/jcsm.8674

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  42 in total

1.  Home-based Approach Noninferior to Hospital-based Approach in Managing Patients with Suspected Obstructive Sleep Apnea Syndrome.

Authors:  David S Hui; Susanna S Ng; Wilson W S Tam
Journal:  Am J Respir Crit Care Med       Date:  2018-05-01       Impact factor: 21.405

2.  Non-CPAP therapies in obstructive sleep apnoea.

Authors:  W J Randerath; J Verbraecken; S Andreas; G Bettega; A Boudewyns; E Hamans; F Jalbert; J R Paoli; B Sanner; I Smith; B A Stuck; L Lacassagne; M Marklund; J T Maurer; J L Pepin; A Valipour; T Verse; I Fietze
Journal:  Eur Respir J       Date:  2011-03-15       Impact factor: 16.671

3.  Comparison of CPAP titration at home or the sleep laboratory in the sleep apnea hypopnea syndrome.

Authors:  Melanie D Cross; Marjorie Vennelle; Heather M Engleman; Sandra White; Thomas W Mackay; Sarah Twaddle; Neil J Douglas
Journal:  Sleep       Date:  2006-11       Impact factor: 5.849

4.  The Effect of Body Position on Physiological Factors that Contribute to Obstructive Sleep Apnea.

Authors:  Simon A Joosten; Bradley A Edwards; Andrew Wellman; Anthony Turton; Elizabeth M Skuza; Philip J Berger; Garun S Hamilton
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

5.  Portable monitoring and autotitration versus polysomnography for the diagnosis and treatment of sleep apnea.

Authors:  Richard B Berry; Gilbert Hill; Linda Thompson; Valorea McLaurin
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

6.  Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.

Authors:  Lawrence J Epstein; David Kristo; Patrick J Strollo; Norman Friedman; Atul Malhotra; Susheel P Patil; Kannan Ramar; Robert Rogers; Richard J Schwab; Edward M Weaver; Michael D Weinstein
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

7.  Upper-Airway Collapsibility and Loop Gain Predict the Response to Oral Appliance Therapy in Patients with Obstructive Sleep Apnea.

Authors:  Bradley A Edwards; Christopher Andara; Shane Landry; Scott A Sands; Simon A Joosten; Robert L Owens; David P White; Garun S Hamilton; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

Review 8.  The effectiveness of different mandibular advancement amounts in OSA patients: a systematic review and meta-regression analysis.

Authors:  Maria Lavinia Bartolucci; Francesco Bortolotti; Eugenia Raffaelli; Vincenzo D'Antò; Ambra Michelotti; Giulio Alessandri Bonetti
Journal:  Sleep Breath       Date:  2016-01-15       Impact factor: 2.816

9.  Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.

Authors:  Clete A Kushida; Alejandro Chediak; Richard B Berry; Lee K Brown; David Gozal; Conrad Iber; Sairam Parthasarathy; Stuart F Quan; James A Rowley
Journal:  J Clin Sleep Med       Date:  2008-04-15       Impact factor: 4.062

10.  Polysomnographic Endotyping to Select Patients with Obstructive Sleep Apnea for Oral Appliances.

Authors:  Ahmad A Bamagoos; Peter A Cistulli; Kate Sutherland; Melanie Madronio; Danny J Eckert; Lauren Hess; Bradley A Edwards; Andrew Wellman; Scott A Sands
Journal:  Ann Am Thorac Soc       Date:  2019-11
View more
  1 in total

1.  Fraction of apnea is associated with the required continuous positive airway pressure level and reflects upper airway collapsibility in patients with obstructive sleep apnea.

Authors:  Hideaki Nakayama; Youichiro Takei; Mina Kobayashi; Mariko Yanagihara; Yuichi Inoue
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.